Correlation Between Agios Pharm and Arcturus Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Arcturus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Arcturus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Arcturus Therapeutics Holdings, you can compare the effects of market volatilities on Agios Pharm and Arcturus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Arcturus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Arcturus Therapeutics.

Diversification Opportunities for Agios Pharm and Arcturus Therapeutics

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Agios and Arcturus is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Arcturus Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcturus Therapeutics and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Arcturus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcturus Therapeutics has no effect on the direction of Agios Pharm i.e., Agios Pharm and Arcturus Therapeutics go up and down completely randomly.

Pair Corralation between Agios Pharm and Arcturus Therapeutics

Given the investment horizon of 90 days Agios Pharm is expected to generate 0.72 times more return on investment than Arcturus Therapeutics. However, Agios Pharm is 1.39 times less risky than Arcturus Therapeutics. It trades about 0.28 of its potential returns per unit of risk. Arcturus Therapeutics Holdings is currently generating about -0.05 per unit of risk. If you would invest  4,683  in Agios Pharm on August 30, 2024 and sell it today you would earn a total of  1,183  from holding Agios Pharm or generate 25.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Agios Pharm  vs.  Arcturus Therapeutics Holdings

 Performance 
       Timeline  
Agios Pharm 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Agios Pharm are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Agios Pharm displayed solid returns over the last few months and may actually be approaching a breakup point.
Arcturus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arcturus Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Agios Pharm and Arcturus Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Agios Pharm and Arcturus Therapeutics

The main advantage of trading using opposite Agios Pharm and Arcturus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Arcturus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will offset losses from the drop in Arcturus Therapeutics' long position.
The idea behind Agios Pharm and Arcturus Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio